196 related articles for article (PubMed ID: 36612824)
1. Challenges and Limitations in Distributional Cost-Effectiveness Analysis: A Systematic Literature Review.
Steijger D; Chatterjee C; Groot W; Pavlova M
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612824
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
Meunier A; Longworth L; Gomes M; Ramagopalan S; Garrison LP; Popat S
Pharmacoeconomics; 2023 Aug; 41(8):1011-1025. PubMed ID: 37296369
[TBL] [Abstract][Full Text] [Related]
4. Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.
Ward T; Mujica-Mota RE; Spencer AE; Medina-Lara A
Pharmacoeconomics; 2022 Jan; 40(1):45-64. PubMed ID: 34713423
[TBL] [Abstract][Full Text] [Related]
5. Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges.
Meunier A; Longworth L; Kowal S; Ramagopalan S; Love-Koh J; Griffin S
Value Health; 2023 Jan; 26(1):60-63. PubMed ID: 35941004
[TBL] [Abstract][Full Text] [Related]
6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
7. Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.
Goshua G; Calhoun C; Ito S; James LP; Luviano A; Krishnamurti L; Pandya A
Ann Intern Med; 2023 Jun; 176(6):779-787. PubMed ID: 37247420
[TBL] [Abstract][Full Text] [Related]
8. Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review.
Cadham CJ; Prosser LA
Value Health; 2023 Jun; 26(6):943-952. PubMed ID: 36805575
[TBL] [Abstract][Full Text] [Related]
9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
10. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
[TBL] [Abstract][Full Text] [Related]
11. The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.
Picot J; Cooper K; Bryant J; Clegg AJ
Health Technol Assess; 2011 Dec; 15(41):1-204. PubMed ID: 22146234
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Kowal S; Ng CD; Schuldt R; Sheinson D; Cookson R
Value Health; 2023 Feb; 26(2):216-225. PubMed ID: 36192293
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness studies of vertebral augmentation for osteoporotic vertebral fractures: a systematic review.
Pron G; Hwang M; Smith R; Cheung A; Murphy K
Spine J; 2022 Aug; 22(8):1356-1371. PubMed ID: 35257838
[TBL] [Abstract][Full Text] [Related]
15. Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analyses.
Stevenson MD; Scope A; Sutcliffe PA; Booth A; Slade P; Parry G; Saxon D; Kalthenthaler E;
Health Technol Assess; 2010 Sep; 14(44):1-107, iii-iv. PubMed ID: 20863477
[TBL] [Abstract][Full Text] [Related]
16. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
17. Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis.
Yang F; Angus C; Duarte A; Gillespie D; Walker S; Griffin S
Med Decis Making; 2020 Jul; 40(5):606-618. PubMed ID: 32608317
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review.
Ruiz-Negrón N; Menon J; King JB; Ma J; Bellows BK
Pharmacoeconomics; 2019 May; 37(5):669-688. PubMed ID: 30637713
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
